Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Hedge funds distance themselves from Purdue Pharma

The troubles of Purdue Pharma, the maker of the opioid OxyContin, have led two hedge funds to cut ties with the company as legal consequences from the national opioid abuse and overdose epidemic continue to play out.

HHS teams up with Janssen to treat coronavirus

HHS is extending its existing partnership with pharmaceutical company Janssen Research & Development, which is part of Johnson & Johnson, to develop treatments for the 2019 novel coronavirus, the agency announced.

 

Thumbnail

Unregulated Craiglist drug market rising due to sky-high prices

More Americans afflicted with chronic disease are turning to unregulated markets such as Craigslist to find insulin and other necessary medications because they can’t afford to purchase them at the pharmacy­­.

 

Thumbnail

Study: Universal healthcare system would save lives, improve healthcare

A Medicare for all healthcare system has the potential to improve the availability of services and efficiency of care in the United States, according to a recent study published in The Lancet.

Thumbnail

Healthcare spending closes in on $6K per privately insured person

HCCI analyzed more than 2.5 billion de-identified claims, including those for prescription drugs as well as medical visits, filed from 2014 to 2018 with Aetna, Humana, Kaiser Permanente and UnitedHealthcare.

Thumbnail

Fewer struggling to pay medical bills—surprise or not—but millions still set back

Citing data previously published from the National Health Interview Survey, authors Amy Cha, PhD, MPH, and Robin Cohen, PhD, point out that major medical bills piling up for one member of a family tend to weaken the entire household.

Thumbnail

China ramps up AI surveillance in face of coronavirus outbreak

Big-name Chinese technology vendors have responded to the Wuhan coronavirus outbreak by using more AI surveillance on the general public than ever before.

Thumbnail

Health impacts are mixed when the minimum wage is raised

Where to set the minimum wage, or whether to set one at all, is one of the most contentious political questions in these divided times. A new study focused on health outcomes may give argumentation ammunition to all sides.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup